Emily Schmidt

Emily Schmidt is the Director of Autologous Process & Analytical Development at Adaptimmune. Emily previously worked as an Associate Director and Line-Managing Principal Scientist in the same field. Before that, Emily was a Senior Scientist at Kennedy Institute of Rheumatology. Emily completed their PhD in Immunology at the University of Birmingham after obtaining a degree in Biochemistry from the University of Bath. Emily has also gained experience in cellular immunology at GlaxoSmithKline and target validation at AstraZeneca during their academic journey.